Reviva Pharmaceuticals Holdings (RVPH) Return on Equity [ROE] (2019 - 2026)
Reviva Pharmaceuticals Holdings' Return on Equity [ROE] was -79.77% in Q2 2026, up 47.70 percentage points from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Return on Equity [ROE] (2019 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Reviva Pharmaceuticals Holdings came in at -419.97%, up 496.20 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -347.67 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -916.17% in FY2024 (-359.79 pp) and -556.38% in FY2023.
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q1 2022.
- Per Business Quant data, RVPH's Return on Equity [ROE] in the three quarters before Q2 2026 was -127.48% (Q1 2026), -301.04% (Q4 2025) and -1112.64% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Reviva Pharmaceuticals Holdings | 6.56 Mn | 6.56 Mn | - | -79.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -79.77% |
| Mar 31, 2026 | -127.48% |
| Dec 31, 2025 | -301.04% |
| Sep 30, 2025 | -1,112.64% |
| Mar 31, 2024 | -1,822.26% |
| Mar 31, 2023 | -554.52% |
| Dec 31, 2022 | -217.81% |
| Sep 30, 2022 | -118.43% |
| Jun 30, 2022 | -99.78% |
| Mar 31, 2022 | -59.69% |
| Dec 31, 2021 | -27.96% |
| Sep 30, 2021 | -15.54% |
| Jun 30, 2021 | -17.60% |
| Mar 31, 2021 | -43.97% |
| Nov 30, 2020 | -19.70% |
| Aug 31, 2020 | -7.51% |
| May 31, 2020 | 9.56% |
| Nov 30, 2019 | 20.34% |
| Aug 31, 2019 | 17.62% |
| May 31, 2019 | 12.20% |
API Access
Reviva Pharmaceuticals Holdings Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();